Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

Vanessa Xanthakis; Martin G. Larson; Kai C. Wollert; Jayashri Aragam; Susan Cheng; Jennifer E. Ho; Erin Coglianese; Daniel Levy; Wilson S. Colucci; G. Michael Felker; Emelia Benjamin; James L. Januzzi; Thomas J. Wang; Ramachandran S. Vasan

doi:10.1161/jaha.113.000399

Back

Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

Article 2013 en

Abstract

1 min read

Our community-based investigation suggests that cardiac stress biomarkers are associated with LVH and LVSD but may have limited clinical utility as screening tools.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction

Ramachandran S. Vasan, Emelia Benjamin, Martin G. Larson, Eric Leip, Thomas J. Wang, Peter W.F. Wilson, Daniel Levy

Article2003

The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening

Thomas J. Wang, Daniel Levy, Emelia Benjamin, Ramachandran S. Vasan

Article2023

Stricter blood pressure control reduces rate of left ventricular hypertrophy and diastolic dysfunction in ethnic minority groups in the UK:E-ECHOES study

Alena Shantsila, Eduard Shantsila, Professor Gregory Lip, Paramjit Gill

Article2023

Community echocardiographic left ventricular hypertrophy and mortality in South Asians in the UK: E-ECHOES study

Eduard Shantsila, Alena Shantsila, Nefyn Williams, Professor Gregory Lip, Paramjit Gill

Article2020

Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response

Nicola Tidbury, J. Preston, Wern Yew Ding, José Miguel Rivera‐Caravaca, Francisco Marı́n, Professor Gregory Lip